推荐产品
一般描述
Added to Basal Medium to create Growth Medium
Human endothelial cell growth supplement is added to the basal medium to create growth medium. The complete growth medium (equivalent to Cat# 211-500) is optimized and best-suited for angiogenesis and other physiological studies.
应用
Endothelial Cell Growth Supplement (15ml) has been used as a supplement for culturing:
- human type II alveolar cells
- human umbilical vein endothelial cells (HUVEC)
- human pulmonary artery endothelial cells (HPAECs)
质量
Each lot was tested for the ability to support plating, spreading and proliferation
制备说明
contained in protocol
储存分类代码
10 - Combustible liquids
WGK
WGK 3
法规信息
新产品
Koustav Ganguly et al.
Scientific reports, 10(1), 20460-20460 (2020-11-26)
Limited toxicity data on electronic cigarette (ECIG) impede evidence-based policy recommendations. We compared two popular mixed fruit flavored ECIG-liquids with and without nicotine aerosolized at 40 W (E-smoke) with respect to particle number concentrations, chemical composition, and response on physiologically relevant
Michelle V Mouritzen et al.
Journal of peptide science : an official publication of the European Peptide Society, 24(7), e3093-e3093 (2018-06-26)
Neurotensin, substance P, and insulin have been demonstrated to improve wound healing in vivo. However, the mechanism behind their effect is still not fully understood. This study investigates the effects leading to enhanced scratch closure by these peptides in vitro.
Hong Xue et al.
International journal of chronic obstructive pulmonary disease, 16, 1329-1345 (2021-05-20)
Etanercept (ETN), a tumor necrosis factor-α (TNF-α) inhibitor, has been applied in the treatment of many diseases. However, whether it has effects on chronic obstructive pulmonary disease (COPD) and its interaction with tumor necrosis factor receptor 1 (TNFR1) remained unknown.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门